- Investor's Business Daily•2 days ago
Axovant was unconcerned after rival Lundbeck failed a key hurdle in Phase 3 testing for its newest Alzheimer's treatment drug.
- Zacks•2 days ago
The Dow experienced a strong week of gains, buoyed by the Fed's decision to leave rates unchanged in September.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||34.09 x 200|
|Ask||34.28 x 100|
|Day's Range||34.01 - 34.37|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.37|
|Avg Vol (3m)||19,379,250|
|Dividend & Yield||1.20 (3.50%)|